Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity
- PMID: 10984501
- PMCID: PMC27086
- DOI: 10.1073/pnas.170297297
Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity
Abstract
Single-chain antibody mutants have been evolved in vitro with antigen-binding equilibrium dissociation constant K(d) = 48 fM and slower dissociation kinetics (half-time > 5 days) than those for the streptavidin-biotin complex. These mutants possess the highest monovalent ligand-binding affinity yet reported for an engineered protein by over two orders of magnitude. Optimal kinetic screening of randomly mutagenized libraries of 10(5)-10(7) yeast surface-displayed antibodies enabled a >1,000-fold decrease in the rate of dissociation after four cycles of affinity mutagenesis and screening. The consensus mutations are generally nonconservative by comparison with naturally occurring mouse Fv sequences and with residues that do not contact the fluorescein antigen in the wild-type complex. The existence of these mutants demonstrates that the antibody Fv architecture is not intrinsically responsible for an antigen-binding affinity ceiling during in vivo affinity maturation.
Figures
Comment in
-
Breaking the affinity ceiling for antibodies and T cell receptors.Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10679-81. doi: 10.1073/pnas.97.20.10679. Proc Natl Acad Sci U S A. 2000. PMID: 11005851 Free PMC article. No abstract available.
Similar articles
-
Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.J Mol Biol. 1996 Nov 8;263(4):551-67. doi: 10.1006/jmbi.1996.0598. J Mol Biol. 1996. PMID: 8918938
-
Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.Cancer Res. 2000 Nov 15;60(22):6434-40. Cancer Res. 2000. PMID: 11103810
-
Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries.J Mol Biol. 2001 Jun 8;309(3):671-85. doi: 10.1006/jmbi.2001.4663. J Mol Biol. 2001. PMID: 11397088
-
Yeast display of antibody fragments: a discovery and characterization platform.J Immunol Methods. 2004 Jul;290(1-2):69-80. doi: 10.1016/j.jim.2004.04.009. J Immunol Methods. 2004. PMID: 15261572 Review.
-
Pharmacokinetics and biodistribution of genetically-engineered antibodies.Q J Nucl Med. 1998 Dec;42(4):225-41. Q J Nucl Med. 1998. PMID: 9973838 Review.
Cited by
-
Physical extraction of antigen and information.Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2320537121. doi: 10.1073/pnas.2320537121. Epub 2024 Sep 20. Proc Natl Acad Sci U S A. 2024. PMID: 39302963 Free PMC article.
-
Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating.Protein Eng Des Sel. 2010 Apr;23(4):311-9. doi: 10.1093/protein/gzq001. Epub 2010 Feb 15. Protein Eng Des Sel. 2010. PMID: 20156888 Free PMC article.
-
Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview.Transgenic Res. 2007 Jun;16(3):315-32. doi: 10.1007/s11248-007-9095-x. Epub 2007 Apr 14. Transgenic Res. 2007. PMID: 17436059 Free PMC article. Review.
-
Adhesion through single peptide aptamers.J Phys Chem A. 2011 Apr 28;115(16):3657-64. doi: 10.1021/jp1031493. Epub 2010 Aug 26. J Phys Chem A. 2011. PMID: 20795685 Free PMC article.
-
High-throughput saturation mutagenesis generates a high-affinity antibody against SARS-CoV-2 variants using protein surface display assay on a human cell.PLoS Pathog. 2023 Feb 1;19(2):e1011119. doi: 10.1371/journal.ppat.1011119. eCollection 2023 Feb. PLoS Pathog. 2023. PMID: 36724179 Free PMC article.
References
-
- Halim N S. The Scientist. 2000;14:16–17.
-
- Batista F D, Neuberger M S. Immunity. 1998;8:751–759. - PubMed
-
- Adams G P, Schier R, Marshall K, Wolf E J, McCall A M, Marks J D, Weiner L M. Cancer Res. 1998;58:485–490. - PubMed
-
- Colcher D, Pavlinkova G, Beresford G, Booth B J, Choudhury A, Batra S K. Q J Nucl Med. 1998;42:225–241. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
